Close Menu

NEW YORK (360Dx) — Genspeed announced today that it has partnered with Danish medical technology firm Virogates to develop a rapid point-of-care test for medical risk classification.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.